ArticlePloS one2022
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers.
Navneet Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticlePloS one2022
Navneet Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.